Prognostic characterization of immune molecular subtypes in non-small cell lung cancer to immunotherapy
Abstract Background Non-small cell lung cancer (NSCLC) was usually associated with poor prognosis and invalid therapeutical response to immunotherapy due to biological heterogeneity. It is urgent to screen reliable biomarkers, especially immunotherapy-associated biomarkers, that can predict outcomes...
Enregistré dans:
| Auteurs principaux: | , , , |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
BMC
2021
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/22ade93edf0944fea407007df5cc0fcb |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|